<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel>
<title>Microbial Metallomics — Commentary</title><link>https://microbialmetallomics.com</link><description>New writing, research summaries, and paper reviews from Microbial Metallomics.</description><language>en-US</language><atom:link href="https://microbialmetallomics.com/feeds/commentary.xml" rel="self" type="application/rss+xml"/>
<item><title>Tampon Metals and the Vaginal Microbiome: The Blind Spot in the Risk Assessment</title><link>https://microbialmetallomics.com/blog/tampon-metals-vaginal-microbiome-blind-spot</link><guid isPermaLink="true">https://microbialmetallomics.com/blog/tampon-metals-vaginal-microbiome-blind-spot</guid><dc:creator>Karen Pendergrass</dc:creator><description>A 2026 FDA risk assessment by Jin et al. calls the metals in tampons safe, but only for one endpoint: the fraction absorbed systemically into the blood. That verdict rests on a single word, bioavailable. The vaginal microbes live on the surface, not in the bloodstream, and were never assessed.</description><category>Critical Commentary</category><pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate></item>
</channel></rss>
